Latest Market News

Rapid Lithium Limited has closed its partially underwritten entitlement offer, raising $53,860 with 37 applications, and is now working to place the remaining shortfall by April 2025.

Micro-X Limited has requested an immediate voluntary suspension of its shares on the ASX, pending a forthcoming equity raising announcement expected by February 10.

OncoSil Medical has secured authorization for 120 German hospitals to negotiate funding for its pancreatic cancer treatment device, marking a 43% increase from last year and signaling growing acceptance in Germany’s healthcare system.

SEEK Limited’s proposed acquisition of Xref Limited has hit a major roadblock after Xref shareholders voted against the scheme, falling short of the required 75% approval threshold. Despite strong endorsements, the deal is now terminated, prompting SEEK to reconsider its growth strategy.

Xref Limited’s proposed acquisition by SEEK Limited failed to secure the necessary 75% shareholder approval, leading to the termination of the scheme and a renewed focus on independent growth.

Nufarm’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strategic investments in omega-3 canola, biofuels, and cost-saving initiatives setting the stage for growth in FY25.

Pioneer Lithium has initiated a comprehensive field exploration program at its Skull Creek Uranium Project in Colorado, aiming to refine uranium mineralisation targets through detailed geological and geochemical investigations.

Athena Resources has appointed Peter Jones as Managing Director and CEO, aiming to leverage his extensive Mid-West iron ore experience to advance the high-grade Byro Magnetite Project.

WAT Resources Ltd has successfully produced ferroniobium from its Luni niobium concentrate, marking a key milestone in the West Arunta Project’s development. The proof-of-concept testwork confirms the viability of a conventional production process and sets the stage for further optimisation and product diversification.

Corazon Mining has completed a comprehensive VTEM™ geophysical survey over its MacBride Base and Precious Metals Project in Canada, revealing multiple conductive anomalies that could signal new massive sulphide deposits. The company is now prioritising drill targets with plans to commence drilling in late Q1 2025.

Noxopharm has successfully completed key in vitro safety tests for its SOF-SKN™ lupus drug, paving the way for the upcoming HERACLES Phase 1 clinical trial.

Aeris Environmental has updated its quarterly cash flow report, confirming ongoing operational cash outflows but expressing confidence in maintaining current cash flow levels while exploring new funding avenues.